Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

62.13
BATS BZX Real-Time Price
As of 3:56pm ET
 -0.83 / -1.32%
Today’s Change
47.97
Today|||52-Week Range
64.00
+17.63%
Year-to-Date
Stocks Fall Ahead of Clinton-Trump Debate, Crude Rallies
12:12pm / TheStreet.com - Paid Partner Content
5 Things You Must Know Before the Market Opens Monday
Sep 19 / TheStreet.com - Paid Partner Content
Can You Guess Which Big Pharma Has Raised Its Drug Prices 5 Times Since June 2014?
8:28am / MotleyFool.com - Paid Partner Content
Merck/Pfizer Diabetes Drug Ertugliflozin Positive in Phase III
Sep 16 / Zacks.com - Paid Partner Content
BioLineRx Begins Trial on BL-8040/ Keytruda Combination
Sep 21 / Zacks.com - Paid Partner Content
Europeans are among those most sceptical of vaccine safety
Sep 14 / FT.com - Paid Partner Content
US Indexes Gain Ahead of Central Bank Announcements
Sep 20 / GuruFocus News - Paid Partner Content
New GE, Catepillar & Sinopec Research Reports
Sep 13 / Zacks.com - Paid Partner Content
Sanofi Sues Merck Over Patent Infringement
Sep 20 / GuruFocus News - Paid Partner Content
Biotech Stocks Bounce Back in Monday Trading: 3 Picks
Sep 13 / Zacks.com - Paid Partner Content
Opinions split on Witty regime at GSK
Sep 20 / FT.com - Paid Partner Content
Why Pfizer's Stock Is a Big Gamble Right Now
Sep 13 / MotleyFool.com - Paid Partner Content
Theresa May Assures IBM, Amazon, Goldman Sachs About Brexit
Sep 20 / Zacks.com - Paid Partner Content
Billionaire Battleground: Is It Time to Buy or Sell Gilead Sciences?
Sep 13 / MotleyFool.com - Paid Partner Content
Meet Big Pharma's new female CEO
Sep 20 / CNNMoney.com
How Risky Is Organovo Holdings, Inc.?
Sep 12 / MotleyFool.com - Paid Partner Content
How Safe Is Gilead Sciences Inc. and Its Dividend?
Sep 20 / MotleyFool.com - Paid Partner Content
Better Buy: Merck & Co., Inc. vs. Pfizer
Sep 12 / MotleyFool.com - Paid Partner Content
Stocks Trade Lower Monday With Global Central Bank Uncertainty
Sep 19 / GuruFocus News - Paid Partner Content
Gilead Sciencs, Inc. a Takeover Target? It's Not as Crazy As It Sounds
Sep 12 / MotleyFool.com - Paid Partner Content
Sanofi Fighting a Losing Battle Sues Merck for Alleged Patent Infrigement
Sep 19 / TheStreet.com - Paid Partner Content
Bristol-Myers Squibb misses mark with cancer drug
Aug 30 / FT.com - Paid Partner Content
This Diabetes Breakthrough Is Great News or Terrible News, Depending on Your Perspect...
Sep 19 / MotleyFool.com - Paid Partner Content